论文部分内容阅读
目的:观察麝香保心丸联合西药治疗冠心病临床疗效。方法:120例冠心病患者随机分为对照组和治疗组,每组60例。对照组行西医常规治疗;治疗组在西医常规基础上加服麝香保心丸治疗。疗程均为30天。结果:临床总有效率治疗组96.67%,对照组78.33%,2组临床疗效比较,差异有统计学意义(P<0.05)。心电图总有效率治疗组85.00%,对照组66.67%,2组心电图疗效比较,差异有统计学意义(P<0.05)。2组均无不良发应发生。结论:麝香保心丸联合西药治疗冠心病疗效显著,且无明显不良反应。
Objective: To observe the clinical effect of Shexiang Baoxin Pill combined with Western medicine in treating coronary heart disease. Methods: 120 cases of coronary heart disease were randomly divided into control group and treatment group, 60 cases in each group. The control group was treated routinely with Western medicine. The treatment group was treated with “Shexiang Baoxin Pill” routinely on the basis of Western medicine. The course of treatment is 30 days. Results: The total clinical effective rate was 96.67% in the treatment group and 78.33% in the control group. There was significant difference in clinical curative effect between the two groups (P <0.05). The total effective rate of electrocardiogram was 85.00% in the treatment group and 66.67% in the control group, and the difference was statistically significant between the two groups (P <0.05). No adverse reactions occurred in both groups. Conclusion: The therapeutic effect of Shexiang Baoxin Pill combined with western medicine on coronary heart disease is remarkable, and no obvious adverse reactions.